Manav Rachna International Institute of Research and Studies, Faridabad and Advancells announce Industry-Academia, Noida

Image
ANI
Last Updated : Oct 01 2019 | 7:15 PM IST

Advancells and Manav Rachna International Institute of Research and Studies (MRIIRS), Faridabad announced a research partnership and an exclusive license agreement to promote industry-academia exchange between the two entities.

This collaboration will benefit students, researchers and the wider community in strengthening the research in Healthcare and Biotechnology area for betterment of mankind.

It will also be instrumental in deepening the market insights for stem cell therapy, with focus on optimizing deliverables from channel members.

Advancells Group believes in encouraging and empowering the students at MRIIRS by sharing their experiences and knowledge in the field of Stem Cell Technology, in exchange of which the Advancells Group will get an opportunity to receive education for the several courses and study programmes at the University.

"We are aiming at organizing joint international conferences, symposia, and workshops for our participants and developing other mutually beneficial programs like skill-oriented certificate courses in Stem Cell Technology for both the parties in due course of time," said Vipul Jain, CEO of Advancells.

"We are pleased to collaborate with Advancells, for coming together to undertake meaningful research and hope to utilize each other's expertise with the stem cells pathway to identify promising results that could one day become breakthroughs in healthcare industry," said Dr Sarita Sachdeva, Dean Research, Manav Rachna International Institute of Research and Studies (MRIIRS).

"As we continue to strengthen our collaboration with the help of the MoU, we are thrilled to identify and develop innovative solutions to the problems of mankind today," said Dr Sachin Kadam, CTO of Advancells.

"This partnership represents an exceptional opportunity to operate on a combined level while expanding the potential for our technology into beneficial approaches for all, with this multidisciplinary team, including Advancells, Faculty of Dental Sciences, Department of Biotechnology, and Faculty of Management Studies at MRIIRS," added Dr Sarita.

This specially designed MoU will also serve as an excellent platform for academic promotions of under-graduate and post-graduate students, research scholars, faculty members and staff of MRIIRS to collaboratively work on stem cells and which would lead to publication of research papers under joint authorship.

The collaboration is envisaged to provide impetus to both Advancells and MRIIRS, based on expertise and knowhow.

This story is provided by BusinessWire India. ANI will not be responsible in any way for the content of this article.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 01 2019 | 7:05 PM IST

Next Story